pH-Sensitive Polymeric Delivery Systems for Arthritis Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for rheumatoid arthritis often result in significant side effects due to the non-specific distribution of antirheumatic drugs, leading to ineffective targeting of diseased tissues and increased toxicity in other tissues.
Innovation Solution
Development of water-soluble polymeric delivery systems that specifically target inflamed joints for both therapeutic agents and imaging agents, utilizing a polymer backbone with targeting moieties and linkages that are degradable or non-degradable under physiological conditions, allowing for controlled release and enhanced retention in arthritic tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antirheumatic drugs are used for treating rheumatoid arthritis, then therapeutic effects are achieved, but side effects increase due to non-specific distribution
Solution Approach 1:
The patent applies local quality by modifying the drug delivery system to have different properties at different locations: the polymeric carrier maintains stability in circulation (systemic level) while the drug is released specifically at the inflamed joint site (local level). This is achieved through pH-sensitive linkages that remain intact in blood pH but cleave in the acidic environment of inflamed joints, enabling targeted therapy that maintains efficacy while reducing systemic side effects.
Solution Approach 2:
The patent uses a polymeric carrier as an intermediary between the drug and the target tissue. This carrier facilitates selective delivery by exploiting the enhanced permeability of inflamed joint vasculature and the acidic microenvironment, acting as a mediator that concentrates the drug at the disease site while minimizing exposure to healthy tissues, thereby resolving the contradiction between therapeutic efficacy and side effects.
2Reliability
If water-soluble polymeric delivery systems are used to target inflamed joints, then drug delivery specificity is improved, but system complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the drug delivery function into distinct modular components: a water-soluble polymeric backbone for solubility and circulation stability, pH-sensitive linkage modules for targeted release, and drug loading sections. This modular segmentation enables systematic design and optimization of each component's function while maintaining overall system manageability despite increased complexity.
Solution Approach 2:
The patent employs composite materials by combining different polymeric components with specific functionalities: water-soluble polymer backbones for biocompatibility, pH-sensitive linkage segments for environmental responsiveness, and drug-conjugating moieties for therapeutic payload delivery. This composite approach creates a multifunctional delivery system that achieves targeted delivery while organizing complexity through functional material integration.
3Quantity of substance
If macromolecular delivery systems are used for tumor targeting, then drug accumulation in target tissue is enhanced, but application to arthritis requires new approaches due to different tissue characteristics
Solution Approach 1:
The patent applies parameter changes by adapting the delivery system design from tumor-targeting to arthritis-targeting parameters. While tumor EPR effect exploits vascular permeability, the arthritis application exploits the acidic pH parameter (pH 5-6.5 in inflamed joints versus pH 7.4 in blood). The pH-sensitive linkages are specifically designed to respond to this pH parameter difference, enabling drug release in inflamed joints while remaining stable in circulation, thus adapting macromolecular delivery principles to a different disease context.
Solution Approach 2:
The patent demonstrates universality by creating a polymeric delivery platform that can be adapted to target different inflammatory conditions (arthritis, other inflammatory diseases) through modular design. The core polymeric structure with pH-sensitive linkages provides a universal mechanism for targeted drug delivery to inflamed tissues regardless of specific disease type, enabling one platform to serve multiple therapeutic applications by changing the attached drug payload.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymeric delivery systems demonstrate preferential accumulation and retention in inflamed joints, reducing side effects by localized drug delivery and providing enhanced imaging capabilities for monitoring disease progression and therapeutic efficacy.
Implementation Method 1
Because of the 'leaky' vasculature and poorly developed lymphatic system, extravasated macromolecules can be efficiently accumulated in the solid tumor. This phenomenon is termed tumor-selective 'enhanced permeability and retention' (EPR)
Implementation Method 2
The linkage (or linkages) between the therapeutic agent (or agents) and the polymer backbone is non-degradable or degradable under physiological conditions
Data Source
AI summary
This invention relates to biotechnology, more particularly, to water-soluble polymeric delivery systems for the imaging, evaluation and/or treatment of rheumatoid arthritis and other inflammatory diseases. Using modern MR imaging techniques, the specific accumulation of macromolecules in arthritic joints in adjuvant-induced arthritis in rats is demonstrated. The strong correlation between the uptake and retention of the MR contrast agent labeled polymer with histopathological features of inflammation and local tissue damage demonstrates the practical applications of the macromolecular delivery system of the invention.